(Q33389637)

English

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

object named as

Peter Bramlage

8

0 references

author name string

Hanno Riess

1

1 reference

Europe PubMed Central

26 July 2017

Uwe Pelzer

2

1 reference

Europe PubMed Central

26 July 2017

Andreas Hilbig

3

1 reference

Europe PubMed Central

26 July 2017

Jens Stieler

4

1 reference

Europe PubMed Central

26 July 2017

Bernhard Opitz

5

1 reference

Europe PubMed Central

26 July 2017

Theo Scholten

6

1 reference

Europe PubMed Central

26 July 2017

Dörte Kauschat-Brüning

7

1 reference

Europe PubMed Central

26 July 2017

Bernd Dörken

9

1 reference

Europe PubMed Central

26 July 2017

Helmut Oettle

10

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

5 December 2008

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

8

1 reference

Europe PubMed Central

26 July 2017

361

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-361

0 references

Coagulation, anticoagulation and pancreatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Cancer statistics, 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Pancreatic cancer and thromboembolic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Two patients with arterial thromboembolism among 311 patients with adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Complete clinical remission in a patient with advanced pancreatic cancer using mitomycin C-based chemotherapy: the role of adjunctive heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Spontaneous arterial thrombosis in association with pancreatic carcinoma: diagnosis and interventional management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

28 July 2018

High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613915

31 October 2018

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-361

21 January 2018

Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimates of cancer incidence and mortality in Europe in 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in relative risk of venous thromboembolism in different cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of metastatic non-small cell lung cancer with low molecular weight heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the pancreas; diagnostic and operative criteria based on 100 consecutive autopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the pancreas; effect of histological types and grade of malignancy on its behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19055847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-361

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33389637&oldid=1644380775"